A 6-mm Implant Is Not a Shortcut: What 10 Years of Evidence Actually Show

A 6-mm implant instead of a sinus lift is not an improvisation. In the randomized trial with the longest follow-up we have, patients who received 6-mm implants in the atrophic posterior maxilla reached 96.0 percent implant survival at 10 years, against 100 percent for longer implants placed with simultaneous sinus grafting. That difference was not statistically significant, although a trial this size cannot formally prove the two approaches equivalent. The short-implant patients also spent 22 fewer minutes in surgery and, at the trial's own prices, paid roughly half as much. None of that makes a 6-mm implant a shortcut. It is a different protocol with its own entry criteria, and the moment you ignore them, the evidence stops backing you up.

A few days ago I published a short video saying exactly that sentence: a 6-mm implant is not a shortcut. It became that week's most engaged content on every channel where I published it, which tells me the topic hits a nerve. So this article is the long version: what the trials actually measured, what the numbers say, and, more importantly, the rules that were baked into those trials and quietly disappear when we retell the story at a study club.

The trial that answers the question

Most of the numbers above come from one remarkable study: a multicenter randomized controlled trial run across centers in Zurich, Vienna, Szczecin, Santiago de Compostela and Connecticut. The design was simple and honest. One hundred and one patients, all missing teeth in the posterior maxilla, all with a residual ridge height of 5 to 7 millimeters below the sinus floor. Half were randomized to 6-mm implants placed in native bone. The other half received 11 to 15-mm implants placed simultaneously with a lateral window sinus lift. Everyone was restored with single crowns, then followed for a decade.

The team published results at 1 year, 3 years, and finally the 10-year data in the Journal of Clinical Periodontology in 2024. Here is the survival story over time.

Two implants lost over ten years, in one arm, out of a hundred patients, in a trial too small to declare the arms equal. What the numbers do pin down is where the certain costs sit: the grafted group reached its perfect record through an added simultaneous grafting procedure, with the extra operative time, morbidity and money that carries.

What the sinus lift actually costs the patient

I place implants and I do sinus lifts, and I want to be fair to both. The lateral window sinus lift is one of the best documented procedures in implant dentistry; I wrote a whole article on choosing between the lateral window and the transcrestal approach. The honest comparison is not "graft bad, short good". It is: what does the graft buy you, and what does it cost, in a site where a 6-mm implant would also work?

The morbidity signal goes beyond this single trial. A 2019 systematic review and meta-analysis of seven RCTs found that going short meant significantly fewer post-surgical reactions, and about a ninth of the risk on the scariest line item: the risk ratio for sinus perforation or infection was 0.11 (95% CI 0.02 to 0.63) compared with sinus floor elevation. You cannot perforate a membrane you never lifted.

Patients feel this difference. The 1-year report of the trial, which tracked quality-of-life scores (OHIP-49) through the healing phase, concluded that short implants were more favorable for short-term patient morbidity, treatment time and price. Ten years later, the OHIP scores of the two groups were statistically indistinguishable. Which is exactly the point: same destination, gentler road.

The bigger evidence picture

One trial, even a good one, is one trial. So let me stack the rest of the pile on the table.

The University of Michigan group meta-analyzed 18 RCTs with 1,612 implants in 2019: no survival difference at 1 or 3 years between extra-short (6 mm or less) and long (10 mm or more) implants, with less marginal bone loss, fewer biological complications, shorter surgical time and lower cost on the short side. The trade they flagged went the other way for prosthetics, where complications tended to favor the longer implants. Short implants carry taller crowns, and porcelain does not read meta-analyses.

In 2024 an updated systematic review with trial sequential analysis, now 19 RCTs and 2,214 implants, graded the certainty of all of it. The conclusion is worth quoting almost verbatim because it draws the exact boundary of what we know: based on moderate to high certainty evidence, 6-mm implants may be used as an alternative to sinus lift, and implants of 6 mm or less perform like standard implants in native bone and full-arch cases in either jaw. For everything else, the evidence is inconclusive or insufficient.

The ten-year layer deserves its own honest paragraph, because it grew between 2023 and 2026 and it is not one-sided. A second randomized trial in the posterior maxilla, from the Groningen group, followed single crowns on 6-mm implants against 11-mm implants with sinus augmentation for a decade: survival 89.5 versus 90.9 percent in a very small sample of 41 implants, with stable bone and happy patients in both arms. The Zurich single-crown trial I cite below for its reassuring 3-year results also published a 10-year update, in native posterior bone rather than sinus territory: 85.7 percent for 6-mm implants versus 97.1 percent for 10-mm implants, p = .072, with most losses in the mandible as late, non-inflammatory losses of osseointegration. And a 2026 pooled analysis of all ten-year data on implants of 6 mm or less estimated 91.2 percent patient-level survival overall, while its paired analysis of four RCTs found slightly lower ten-year survival than standard implants, risk ratio 0.920 (95% CI 0.857 to 0.987). That pooled picture mixes jaws and indications, so it does not overturn the maxilla-specific trials above. What it does retire is any claim that ten-year equivalence is settled. Through five years the data are solid; at ten they are encouraging in the sinus-lift scenario and genuinely mixed outside it.

And because I promised honesty: the 2018 ITI Consensus Conference looked at the same literature and kept one caveat that deserves to survive every retelling. Across studies, short implants showed survival ranging from 86.7 to 100 percent, against 95 to 100 percent for standard implants, with a failure risk ratio of 1.24 that was not statistically significant but came with a wide confidence interval. Their wording was precise: short implants are a valid option to avoid augmentation morbidity, however they reveal a higher variability and lower predictability in survival rates. My plain-language reading of that spread, and it is an interpretation rather than a trial result: when short implants are done well they match long ones, but the distance between well and badly done is wider. The protocol is less forgiving. That is the opposite of a shortcut.

The rules that make 6 mm work

If you strip the trials down to their inclusion criteria and methods, the "rules" of the 6-mm protocol write themselves. Remember what those trials actually were: delayed loading, single crowns, one implant system per trial, experienced surgical centers, and structured maintenance for a decade. The further your case drifts from that recipe, the less these numbers apply. This is the part I wish fit into a 60-second video.

The 60-second version

This is the video that started the conversation. If the article is the textbook chapter, this is the elevator pitch.

What I tell patients, and what I tell colleagues

To a patient with 6 mm of bone under a healthy sinus, I now say something like this: "There are two well studied ways to do this. One rebuilds bone inside your sinus during the same surgery and uses a standard implant; it works very well and adds a grafting step. The other uses a shorter implant in the bone you already have; studies following patients for up to ten years have found no clear difference in outcomes for cases like yours, with less surgery, a faster recovery and lower cost. Both are legitimate. Here is why I lean toward one for you." That last sentence matters, because the lean changes with the anatomy, the neighboring teeth, the patient's tolerance for surgery, and my honest read of my own primary-stability chances.

To colleagues, my message is the one from the video, expanded by one clause. A 6-mm implant is not a shortcut; it is a documented protocol with entry criteria, and the discipline is in the criteria. The moment "short implants work" becomes "I never need to graft again", we have replaced one dogma with another. The sinus lift did not become a bad operation in 2024. It became one of two good answers for a specific site, and our job is matching the answer to the site instead of to our habits.

Frequently asked questions

Are 6-mm implants as good as regular implants with a sinus lift?

In the right site, the randomized data are reassuring. The two trials that reached 10 years in the posterior maxilla with 5 to 7 mm of residual ridge found no significant survival difference (96.0 versus 100 percent in one, 89.5 versus 90.9 percent in the other), with shorter surgery, fewer surgical complications and lower cost for the 6-mm option. Certainty is moderate to high at 5 years; both 10-year trials are small, so formal long-term equivalence is not proven.

How much bone do you need for a 6-mm implant?

The trials behind these numbers enrolled patients with 5 to 7 mm of residual ridge height below the sinus. A 6-mm implant also needs enough ridge width for its diameter, and the safety margin to the sinus floor still applies. Below roughly 5 mm of height, the randomized evidence for skipping the graft runs out.

Do short implants fail more often?

At 1 to 5 years, meta-analyses of randomized trials show no survival difference against longer implants with augmentation. At 10 years the picture is more nuanced: a 2026 pooled analysis of four RCTs across mixed indications found slightly lower survival for short implants (risk ratio 0.920 at patient level), and the Zurich native-bone trial reported 85.7 versus 97.1 percent (p = .072), with losses concentrated in the mandible. The 2018 ITI consensus flagged the same theme as higher variability across studies (survival 86.7 to 100 percent): the technique is less forgiving of poor case selection and execution, even though its best results match standard implants.

Are 4-mm ultrashort implants also an alternative to sinus lift?

Not with today's evidence. The 2024 systematic review that supports 6-mm implants as a sinus lift alternative explicitly found the data for 4-mm and 5-mm implants in that role inconclusive or insufficient. The 6-mm conclusion does not automatically transfer to shorter lengths.

Go deeper on implant treatment planning

If this decision framework is useful, two resources pair well with it. My speaker pack How to Solve the More Common Bone Defects in Implant Dentistry covers the augmentation side of the equation, ready to present. And for the shelf, Misch's Contemporary Implant Dentistry (fourth edition, edited by Randolph Resnik) remains the deepest single reference on treatment planning fundamentals, including crown-to-implant ratio and bone density protocols.

Get the Misch textbook

Disclosure: the book link is a geo-targeted affiliate link. If you buy through it, Periospot earns a small commission at no extra cost to you. It helps keep articles like this one free.